Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) metabolism pathways represent the integrated network of enzymatic and non-enzymatic processes that regulate the production and elimination of oxygen-derived molecules like superoxide and hydrogen peroxide (Sies et al., 2017, Nature Reviews Molecular Cell Biology). These pathways are fundamental to cellular life, facilitating critical signaling functions in cell growth, differentiation, and immune responses (Pizzino et al., 2017, Oxidative Medicine and Cellular Longevity). Key molecular components include ROS-generating enzymes like NADPH oxidases (NOX) and antioxidant defenses such as superoxide dismutase (SOD), catalase, and the glutathione system (UniProt P04179). When the balance between ROS production and scavenging is disrupted, oxidative stress occurs, leading to cumulative damage to cellular macromolecules including DNA, proteins, and lipids (NIH, StatPearls, 2023). This dysfunction is implicated in the pathogenesis of diverse conditions, including cancer, cardiovascular disease, and neurodegenerative disorders like Alzheimer's disease (PubMed, PMID: 29170645). Therapeutic interventions targeting these pathways include antioxidant supplements, Nrf2 activators, and specific enzyme inhibitors, though achieving selectivity remains a major clinical hurdle (PubChem CID 12035).
Drugs modulate ROS metabolism through several distinct mechanisms: direct scavenging of reactive species (antioxidants), pharmacological inhibition of ROS-generating enzymes such as NADPH oxidase (NOX) or xanthine oxidase, and the induction of endogenous antioxidant defense systems via the activation of the Nrf2/ARE signaling pathway (Pizzino et al., 2017, Oxidative Medicine and Cellular Longevity; PubChem CID 12035).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species metabolism pathways (ROS metabolism).